The global Keytruda market is expected to achieve a CAGR of 8.9% from 2023 to 2032, with the valuation anticipated to reach $54 billion
Throughout medicine, but perhaps most critically in addiction care, the main predictor of treatment success is often the patient's motivation and ability to access and maintain long-term medication adherence
This once-weekly, injectable medication is approved to treat type 2 diabetes and mimics your bodys natural GLP-1, a gut hormone that plays a role in regulating your appetite, digestion, and blood sugar
Prolonged signaling of backbone-modified glucagon-like peptide- 1 analogues with diverse receptor trafficking
Patients with a history of pancreatitis (inflammation of the pancreas) or those who have had thyroid cancer or a family history of medullary thyroid cancer should avoid semaglutide due to potential risks
Not just maintained, but continued losing weight past the one-year mark